Evaxion Biotech A/S
EVAX
$1.65
$0.063.77%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -10.20M | -12.55M | -12.55M |
| Total Depreciation and Amortization | -- | -- | 315.00K | 771.00K | 771.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 1.78M | 1.89M | 1.89M |
| Change in Net Operating Assets | -- | -- | 1.71M | -327.00K | -327.00K |
| Cash from Operations | -- | -- | -6.40M | -10.22M | -10.22M |
| Capital Expenditure | -- | -- | -64.00K | -4.00K | -4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | -5.00K | -5.00K |
| Cash from Investing | -- | -- | -64.00K | -9.00K | -9.00K |
| Total Debt Issued | -- | -- | 65.00K | -19.00K | -19.00K |
| Total Debt Repaid | -- | -- | -237.00K | -224.00K | -224.00K |
| Issuance of Common Stock | -- | -- | 3.20M | 534.00K | 534.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 2.33M | 351.00K | 351.00K |
| Cash from Financing | -- | -- | 5.35M | 642.00K | 642.00K |
| Foreign Exchange rate Adjustments | -- | -- | -428.00K | 406.00K | 406.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -1.54M | -9.18M | -9.18M |